Prevalence of non-penicillin-susceptible group B streptococcus in philadelphia and specificity of penicillin resistance screening methods

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1468-1469

  Kasahara, Kei ^a,b   Baltus, Andrew J ^b   Lee, Sun Hwa ^b,c   Edelstein, Martha A ^b   Edelstein, Paul H ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NeoDin Medical Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CEFTIZOXIME; OXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION; DRUG SENSITIVITY; HUMAN; METHODOLOGY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING; STREPTOCOCCUS GROUP A; UNITED STATES;

ANTI-BACTERIAL AGENTS; CEFTIZOXIME; HUMANS; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PENICILLIN RESISTANCE; PHILADELPHIA; PREVALENCE; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS SP. 'GROUP B';

EID: 77950497384     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02296-09     Document Type: Article

References (9)

1. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Dahesh, S., M. E. Hensler, N. M. Van Sorge, R. E. Gertz, Jr., S. Schrag, V. Nizet, and B. W. Beall. 2008. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother. 52:2915-2918.
3. Kimura, K., S. Suzuki, J. Wachino, H. Kurokawa, K. Yamane, N. Shibata, N. Nagano, H. Kato, K. Shibayama, and Y. Arakawa. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:2890-2897.
4. Kimura, K., J. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, N. Shibata, and Y. Arakawa. 2008. Practical disk diffusion tests for detecting group B streptococcus with reduced penicillin susceptibility, abstr. D-2248. Abstr. 48th Annu. Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
5. Kimura, K., J. I. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, N. Shibata, and Y. Arakawa. 2009. Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. J. Clin. Microbiol. 47: 4154-4157.
6. Persson, E., S. Berg, H. Bergseng, K. Bergh, R. Valso-Lyng, and B. Trollfors. 2008. Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988-2001. Scand. J. Infect. Dis. 40:308-313.
7. 7. Phares, C. R., R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffher, S. M. Zansky, K. Gershman, K. R. Stefonek, B. A. Albanese, E. R. Zell, A. Schuchat, and S. J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299:2056-2065. (Pubitemid 351656587)
8. Schrag, S. J., S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20.
9. Simoes, J. A., A. A. Aroutcheva, I. Heimler, and S. Faro. 2004. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect. Dis. Obstet. Gynecol. 12:1-8.